Collegium Pharmaceutical Inc (COLL) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 
Collegium Pharmaceutical Inc   (NASDAQ: COLL)
 

Collegium Pharmaceutical Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the second quarter 2026, Collegium Pharmaceutical Inc 's inventory turnover ratio sequentially decreased to 4.99 in the second quarter 2026, unsurprisingly, as the Collegium Pharmaceutical Inc markets continue to deteriorate, and COLL's faces growing challenges to bring down its inventories. Collegium Pharmaceutical Inc 's average inventory processing period in the Jun 30 2026 quarter, has increased to 73 days, from 57 days, in the Mar 31 2026 quarter.

Within Healthcare sector 61 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 396 in the first quarter 2026, to 656.

COLL Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Collegium Pharmaceutical Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

COLL Inventory Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Inventory Growth 196.92 % 14.84 % 15.05 % 0.05 % 36.92 %
Y / Y Cost of Sales Growth 47.11 % -75 % -7.88 % 29.03 % 46.3 %
Inventory Turnover Ratio (TTM) 4.99 6.41 8.19 8.66 8.18
COLL's Total Ranking # 656 # 396 # 187 # 402 #
Average inventory processing period 73 57 45 42 45
Seq. Inventory Growth 165.01 % 4.47 % 7.52 % -0.25 % 2.5 %
Seq. Cost of Sales Growth 481.09 % -74.05 % -3.66 % 1.27 % -1.25 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 11
Healthcare Sector # 62
Overall Market # 656

Inventory Turnover Ratio Statistics
High Average Low
22.98 9.6 0.04
(Mar 31 2020)   (Dec 31 2016)



COLL Company Profile >> Back to COLL Efficiency Comparisons >> Compare COLL Inventory Turnover Ratio to its Competitors

Financial Statements
Collegium Pharmaceutical Inc 's Inventories $ 113 Millions Visit COLL's Balance sheet
Collegium Pharmaceutical Inc 's Cost of Revenues TTM $ 293 Millions Visit COLL's Income Statement
What are COLL's Sales? Visit COLL's Sales by Segment

Other Inventory Turnover Ratios
Collegium Pharmaceutical Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
COLL's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for COLL's Competitors
Inventory Turnover Ratio for COLL's Suppliers
Inventory Turnover Ratio for COLL's Customers

You may also want to know
COLL's Sales Growth Rates COLL's Pe Price to earnings ratio COLL's Receivables Turnover Ratio COLL's Stock Quote
COLL's Net Income Growth Rates COLL's Ps Price to Sales ratio COLL's Sales per Employee COLL's Asset Turnover Ratio
COLL's Net Margin COLL's Pb Price to Book ratio COLL's Financial Strength Ratios COLL's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Adm Tronics Unlimited Inc   6.05 $ 1.970  Millions$ 0  Millions
Sharps Technology Inc   5.68 $ 2.869  Millions$ 1  Millions
Transmedics Group Inc   5.59 $ 276.120  Millions$ 49  Millions
Opko Health Inc   5.42 $ 348.206  Millions$ 64  Millions
Charles River Laboratories International inc   5.39 $ 1,761.363  Millions$ 327  Millions
Tactile Systems Technology Inc   5.12 $ 81.349  Millions$ 16  Millions
Integer Holdings Corporation  5.03 $ 1,369.168  Millions$ 272  Millions
Harrow Inc   4.93 $ 73.636  Millions$ 15  Millions
Ufp Technologies Inc   4.93 $ 452.046  Millions$ 92  Millions
Veracyte Inc   4.84 $ 102.741  Millions$ 21  Millions
West Pharmaceutical Services Inc   4.72 $ 2,103.100  Millions$ 445  Millions
Henry Schein Inc   4.68 $ 9,342.000  Millions$ 1,997  Millions
Guardant Health Inc   4.53 $ 413.947  Millions$ 91  Millions
Idexx Laboratories Inc  4.44 $ 1,714.440  Millions$ 386  Millions
Adc Therapeutics Sa  4.17 $ 5.806  Millions$ 1  Millions
Scilex Holding Company  4.08 $ 14.867  Millions$ 4  Millions
Medinotec Inc   4.08 $ 4.736  Millions$ 1  Millions
3m Company  4.07 $ 15,258.000  Millions$ 3,754  Millions
Electromed Inc   4.02 $ 14.133  Millions$ 4  Millions
Novocure Limited  4.02 $ 166.921  Millions$ 41  Millions
Elite Pharmaceuticals Inc   3.95 $ 78.824  Millions$ 20  Millions
Lftd Partners Inc   3.89 $ 29.233  Millions$ 8  Millions
Pmgc Holdings Inc   3.87 $ 1.364  Millions$ 0  Millions
Sonoma Pharmaceuticals Inc   3.83 $ 13.392  Millions$ 3  Millions
Intelligent Bio Solutions Inc   3.80 $ 2.165  Millions$ 1  Millions
Iridex Corp  3.80 $ 32.517  Millions$ 9  Millions
Teva Pharmaceutical Industries Limited  3.66 $ 8,232.000  Millions$ 2,250  Millions
Neuraxis Inc   3.55 $ 0.783  Millions$ 0  Millions
Beyond Air Inc   3.51 $ 6.447  Millions$ 2  Millions
Nexgel Inc   3.49 $ 7.577  Millions$ 2  Millions

Date modified: 2026-09-06T17:15:04+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.